Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant Acinetobacter baumannii infection at a long-term acute care hospital

Infection Control and Hospital Epidemiology

Volumn 31, Issue 12, 2010, Pages 1236-1241

  Ray, Amy ^a   Perez, Federico ^b   Beltramini, Amanda M ^a   Jakubowycz, Marta ^a   Dimick, Patricia ^a   Jacobs, Michael R ^a   Roman, Kathy ^a   Bonomo, Robert A ^b   Salata, Robert A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BLOOD SAMPLING; CASE CONTROL STUDY; CHROMOSOME; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; HOSPITAL CARE; HUMAN; LONG TERM CARE; MALE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; POLLUTION; POLYMERASE CHAIN REACTION; RISK FACTOR; SPUTUM ANALYSIS; TERTIARY HEALTH CARE; VENTILATOR ASSOCIATED PNEUMONIA; WASTE MANAGEMENT; WOUND CARE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CASE-CONTROL STUDIES; CROSS INFECTION; DECONTAMINATION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; HYDROGEN PEROXIDE; INFECTION CONTROL; LONG-TERM CARE; OHIO; POLYMERASE CHAIN REACTION; RISK FACTORS; VOLATILIZATION;

EID: 78649950309     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/657139     Document Type: Article

References (28)

1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial- resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996-1011.
2. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008;358(12):1271-1281.
3. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36(7):1938-1941.
4. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997;35(6):1394-1397.
5. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24(4):284-295.
6. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538-582.
7. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51(10):3471-3484.
8. Otter JA, Cummins M, Ahmad F, van Tonder C, Drabu YJ. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007;67(2):182-188. (Pubitemid 47534967)
9. Kahnert A, Seiler P, Stein M, Aze B, McDonnell G, Kaufmann SH. Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis. Lett Appl Microbiol 2005;40(6):448-452. (Pubitemid 40769937)
10. Otter JA, Puchowicz M, Ryan D, et al. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol 2009;30(6):574-577.
11. Blythe D, Keenlyside D, Dawson SJ, Galloway A. Environmental contamination due to methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1998;38(1):67-69. (Pubitemid 28127508)
12. Hardy KJ, Gossain S, Henderson N, et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007;66(4):360-368. (Pubitemid 47215547)
13. Maragakis LL, Cosgrove SE, Song X, et al. An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004;292(24):3006-3011.
14. Clinical Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement. M100-S18. Wayne, PA: CLSI, 2008.
15. Saeed S, Fakih MG, Riederer K, Shah AR, Khatib R. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hosp Epidemiol 2006;27(9):981-983.
16. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem- resistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65(2):233-238.
17. Hamill RJ, Houston ED, Georghiou PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122(10): 762-766.
18. Wexler MR, Rhame FS, Blumenthal MN, Cameron SB, Juni BA, Fish LA. Transmission of gram-negative bacilli to asthmatic children via home nebulizers. Ann Allergy 1991;66(3):267-271.
19. Medicare Payment Advisory Commission. Medpac home page. http:// www.medpac.gov. Published 2003. Accessed March 9, 2010.
20. Carson SS, Bach PB, Brzozowski L, Leff A. Outcomes after long-term acute care: an analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med 1999;159(5 Pt 1):1568-1573.
21. Munoz-Price LS. Long-term acute care hospitals. Clin Infect Dis 2009; 49(3):438-443.
22. Furuno JP, Hebden JN, Standiford HC, et al. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 2008;36(7):468-471.
23. Stephens C, Francis SJ, Abell V, DiPersio JR, Wells P. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control 2007;35(4):212-215. (Pubitemid 46670517)
24. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006;50(9):2941-2945. (Pubitemid 44396395)
25. Rodriguez-Baño J, Garcia L, Ramirez E, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach. Am J Infect Control 2009;37(9):715-722.
26. Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008; 47(6):760-767.
27. Rutala WA. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control 1996;24(4):313-342.
28. Wisplinghoff H, Schmitt R, Wohrmann A, Stefanik D, Seifert H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J Hosp Infect 2007;66(2):174-181.